Brief: ADC Therapeutics SA - Selling Shareholders May Offer 14.7 Million Common Shares - SEC Filing
10/11/2025 22:29
Nov 11 (Reuters) - ADC Therapeutics SA ADCT.N: ADC THERAPEUTICS SA - SELLING SHAREHOLDERS MAY OFFER 14.7 MILLION COMMON SHARES - SEC FILING Source text: [ID:n0000950103-25-014521] Further company coverage: ADCT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview